statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	424
RU - Federazione Russa	246
SG - Singapore	139
CN - Cina	68
IT - Italia	67
DE - Germania	41
HK - Hong Kong	34
BR - Brasile	31
VN - Vietnam	31
IE - Irlanda	23
SE - Svezia	18
BD - Bangladesh	17
GB - Regno Unito	15
FI - Finlandia	14
FR - Francia	14
NL - Olanda	14
CA - Canada	12
IN - India	12
KR - Corea	12
JP - Giappone	7
PL - Polonia	6
AT - Austria	4
ID - Indonesia	4
MX - Messico	4
VE - Venezuela	4
AR - Argentina	3
CZ - Repubblica Ceca	3
ES - Italia	3
NG - Nigeria	3
PK - Pakistan	3
TG - Togo	3
BE - Belgio	2
BJ - Benin	2
CH - Svizzera	2
CO - Colombia	2
EC - Ecuador	2
AE - Emirati Arabi Uniti	1
AU - Australia	1
AZ - Azerbaigian	1
BS - Bahamas	1
CL - Cile	1
CR - Costa Rica	1
CY - Cipro	1
DK - Danimarca	1
HN - Honduras	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LT - Lituania	1
LU - Lussemburgo	1
NI - Nicaragua	1
NP - Nepal	1
PH - Filippine	1
PT - Portogallo	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
TR - Turchia	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	1.319

Nome	#
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic	191
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done	165
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned	161
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?	157
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma	145
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer	141
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study	139
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study	118
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it	116
Totale	1.333

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	36	1	7	0	2	3	2	0	2	2	1	4	12
2022/2023	118	4	11	9	18	9	36	0	10	16	0	4	1
2023/2024	94	4	6	7	13	10	14	9	6	6	5	10	4
2024/2025	262	13	11	12	48	6	11	6	11	33	13	36	62
2025/2026	798	49	40	63	130	209	53	61	40	64	43	41	5
Totale													1.333

CATALOGO DEI PRODOTTI DELLA RICERCA